The Dr. said last year, not even cardio issues. Drugs in past...

The Dr. said last year, not even cardio issues. Drugs in past killed the Actin, but also the patient, due to cardio issues. Iam sure Ninja or others here, are way better on that then my general comment.

But yes, she said ready by then and the curious thing is, Interm also did not point/ mention, out any cardio issues with Anisina. So i agree, why not "mid 2015", etc.. ?? If i personally had one ? for GK, that'd be it, based on last few events.

But, i also love how the Interm said, this thing will be re-shaped, if needed. This company is loaded, with serious talent, that always gives each other credit/ acknowledgememt. That's a good sign for various reasons.

I'am expecting a totally different speed that Novogen executes at now.

I believe re-prioritizing will make Anisina priority and good thing is, it's Anisina, that the analyst felt had better potential.

Glta!
Chris